Junyelt (Copper Gluconate, Manganese Gluconate, Potassium Iodide, Sodium Selenite, Zinc Gluconate)

Each element serves as a cofactor for specific enzymes: copper and manganese support oxidative‑stress enzymes, iodine is essential for thyroid hormone production, selenium is part of antioxidant glutathione peroxidase, and zinc participates in numerous metabolic enzymes. Together they maintain antioxidant defenses, protein synthesis and hormonal balance.

The dose of Junyelt is determined by the prescribing clinician based on the patient’s laboratory results, clinical condition and the required amount of each trace element. Dosage is individualized and administered intravenously under medical supervision.

Safety data for Junyelt in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when possible. If used, it should be under close medical supervision with monitoring of maternal and fetal trace element status.

To order Junyelt, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Junyelt combines five essential trace elements in a single intravenous formulation, which can simplify administration compared with using separate single‑element products. This multi‑element approach may reduce infusion time and handling steps, while still delivering the same therapeutic levels required for deficiency correction.

Junyelt must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required for infusion.

Junyelt is administered intravenously by a healthcare professional. The solution is typically diluted in a compatible carrier fluid and infused over a period determined by the prescribed dose and patient tolerance. Infusion rates and monitoring protocols are set by the treating physician.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, acute copper or zinc toxicity leading to neurological symptoms, and significant electrolyte disturbances. Prompt recognition and discontinuation of the infusion, followed by appropriate medical intervention, are essential.

Junyelt should be avoided in patients with known hypersensitivity to any of its components, those with severe renal or hepatic impairment without dose adjustment, and individuals receiving high‑dose elemental supplements that could cause overload. Clinical judgment is required for each case.